Structure-based virtual screening identifies pranlukast as a CD49f antagonist that reduces stemness in MDA-MB-231 breast cancer cellsMarco Velasco-Velazquez,Ines Velazquez-Quesada,Angel Ruiz-Moreno,Diana Casique-Aguirre,Charmina Aguirre-Alvarado,Fabiola Cortes-Mendoza,Marisol de la Fuente-Granada,Mayra Perez-Tapia,Aliesha Gonzalez-Arenas, Aldo Segura-CabreraBRITISH JOURNAL OF CANCER（2018）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
